Travelers Companies, Inc. (TRV) valuation

Share price $302.73 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
9.03×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
1.32×
P/S history →

Price-to-Book

P/B · Latest filing
2.01×
P/B history →

Expectations investing: what does the price imply?

Near-consensus — no material stretch

Rappaport-style reverse-DCF. We start from the current market price ($302.73 × 212.6M shares = $64.36B market cap, $63.75B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: -10.7%
    Scenario holds the analyst consensus (absolute forecast, TTM-anchored) of -10.7%.
  • Target EBIT margin (Y10): 16.2%
    Scenario starts 12.5%, ends 16.2% (3-yr range 8.1%–16.0%).
  • High-growth plateau: 3 years
    Tier default for Y2 at 2.9%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
+16%
Y4–10
+25%
Terminal
+59%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Facts · TTM as of 2026-03-31 (Q12026)

Share price
$302.73
Diluted shares
212.6M
Total debt
$0
Cash & equivalents
$615.0M
Revenue
$48.94B
Pretax income (cont. ops)
$9.45B
Filer does not tag us-gaap:OperatingIncomeLoss; using pretax income from continuing operations as the operating-income base. For banks this is effectively operating income (interest expense is a core cost); for oil majors and some pharma filers it's a close proxy with small non-operating items mixed in.
Pretax margin
19.3%
Operating cash flow
$11.44B
CapEx
Observed YoY growth
4.1%
Analyst current-FY growth
-0.4%
Analyst next-FY growth
2.9%
3-year revenue CAGR
9.9%

Assumptions

Initial revenue growth
-10.7%
from analyst consensus (absolute forecast, TTM-anchored)
(analyst FY-over-FY consensus: -0.4% — shown effective rate normalises it against our TTM base, which spans the current FY partway)
Year-2 growth
2.9%
from analyst next-FY consensus
Starting EBIT margin
12.5%
from 3-year mean EBIT margin (latest FY deviates > 5pp)
Tax rate
19.1%
from 3-year median of EffectiveTaxRate
Starting ROIC
24.4%
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $43.73B -10.7% $5.62B 12.8% $4.54B 23.0% $0 $4.54B 0.917 $4.17B
2 $44.97B 2.9% $5.95B 13.2% $4.81B 21.7% $1.22B $3.59B 0.842 $3.02B
3 $46.26B 2.9% $6.29B 13.6% $5.09B 20.4% $1.36B $3.73B 0.772 $2.88B
4 $47.56B 2.8% $6.64B 14.0% $5.37B 19.0% $1.50B $3.87B 0.708 $2.74B
5 $48.87B 2.8% $7.01B 14.3% $5.67B 17.7% $1.67B $4.00B 0.650 $2.60B
6 $50.19B 2.7% $7.38B 14.7% $5.97B 16.3% $1.86B $4.11B 0.596 $2.45B
7 $51.52B 2.7% $7.77B 15.1% $6.28B 15.0% $2.09B $4.20B 0.547 $2.30B
8 $52.86B 2.6% $8.17B 15.5% $6.61B 13.7% $2.36B $4.25B 0.502 $2.13B
9 $54.21B 2.6% $8.58B 15.8% $6.94B 12.3% $2.69B $4.25B 0.460 $1.96B
10 $55.56B 2.5% $9.00B 16.2% $7.28B 11.0% $3.10B $4.18B 0.422 $1.77B
Sum of PV of FCF (years 1-10) $26.01B

Terminal value

NOPATN+1
$7.46B
ReinvestmentN+1
$1.65B
FCFN+1
$5.81B
Terminal value (undiscounted)
$89.34B
PV of terminal value
$37.74B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $5.81B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF $26.01B
+ PV of terminal value $37.74B
= Enterprise value $63.75B
− Total debt $0
+ Cash & equivalents $615.0M
= Equity value $64.36B
÷ Diluted shares 212.6M
= DCF PV / share $302.73
Market price $302.73
Reconciliation delta −0.0% (≈ 0 by construction)
Full calculation trail Click to expand — every number on this page derived step by step.

0 · TTM reconstruction (anchor: Q12026, 2026-03-31)

The latest filing is a 10-Q, so "base year" revenue / EBIT / OCF / CapEx are reconstructed as trailing-twelve-month values. Per-quarter facts (typical for income-statement items) get summed across four quarters; YTD-cumulative facts (typical for cash-flow items) use prior FY + YTDnow − YTDprior year same quarter.

Revenue
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $11.92B
  • Q4 FY25 (2025-12-31): $12.43B
  • Q3 FY25 (2025-09-30): $12.47B
  • Q2 FY25 (2025-06-30): $12.12B
  • = $48.94B
EBIT
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-31): $2.12B
  • Q4 FY25 (2025-12-31): $3.10B
  • Q3 FY25 (2025-09-30): $2.34B
  • Q2 FY25 (2025-06-30): $1.88B
  • = $9.45B
OCF
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-31): +$10.61B
  • Q1 FY26 (2026-03-31) YTD: +$2.20B
  • Q1 FY25 (2025-03-31) YTD: −$1.36B
  • = $11.44B
Prior-year TTM revenue (growth-calc baseline)
Sum of the four most recent per-quarter values
  • Q1 FY25 (2025-03-31): $11.81B
  • Q4 FY24 (2024-12-31): $12.01B
  • Q3 FY24 (2024-09-30): $11.90B
  • Q2 FY24 (2024-06-30): $11.28B
  • = $47.01B

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $302.73 × 212.6M
             = $64.36B

EV target    = market cap + total debt − cash & equivalents
             = $64.36B + $0 − $615.0M
             = $63.75B
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $9.45B   (19.3% of revenue)
× (1 − tax rate)  = × (1 − 19.1%) = × 0.8089
= NOPAT₀            = $7.64B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $0 + $31.99B − $615.0M
                 = $31.37B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $7.64B / $31.37B
                 = 24.4%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · Growth path construction

Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = -10.7%, Y2 = 2.9%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 2.9% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = -10.7%
Effective Y2 growth after solver bumps = 2.9%
Growth by year:
  Y1 = -10.7%
  Y2 = 2.9%
  Y3 = 2.9%
  Y4 = 2.8%
  Y5 = 2.8%
  Y6 = 2.7%
  Y7 = 2.7%
  Y8 = 2.6%
  Y9 = 2.6%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 12.5%   (source: 3-year mean EBIT margin (latest FY deviates > 5pp))
Target margin (Y10)  = 16.2%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 12.8%
  Y2 = 13.2%
  Y3 = 13.6%
  Y4 = 14.0%
  Y5 = 14.3%
  Y6 = 14.7%
  Y7 = 15.1%
  Y8 = 15.5%
  Y9 = 15.8%
  Y10 = 16.2%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx (—) against the Normalized CapEx (3-yr mean) of — — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx vs the 3-yr mean of — — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 24.4%; ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 23.0%
  Y2 = 21.7%
  Y3 = 20.4%
  Y4 = 19.0%
  Y5 = 17.7%
  Y6 = 16.3%
  Y7 = 15.0%
  Y8 = 13.7%
  Y9 = 12.3%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 16.2% $63.75B −0.0% yes ✓

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $7.28B × (1 + 2.5%)
                    = $7.46B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $182.0M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $182.0M / 11.0%
                    = $1.65B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $7.46B − $1.65B
                    = $5.81B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $5.81B / (9.0% − 2.5%)
                    = $89.34B

PV(TV)              = TV / (1 + WACC)^10
                    = $89.34B / 2.367
                    = $37.74B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $26.01B
+ PV(TV)          = $37.74B
= Enterprise value = $63.75B   (≈ EV target $63.75B by construction)
− Total debt      = $0
+ Cash            = $615.0M
= Equity value    = $64.36B
÷ Diluted shares  = 212.6M
= DCF PV / share  = $302.73

Market price      = $302.73
Reconciliation Δ  = −0.0%   (≈ 0 by construction — the solver anchored on this price)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for TRV (CIK 0000086312); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.